Teladoc Health, Inc. $TDOC Shares Sold by Hsbc Holdings PLC

Key Points

• HSBC Holdings PLC reduced its stake in Teladoc Health by 53.6%, now owning approximately 0.11% of the company, following the sale of 212,946 shares.
• Several institutional investors have increased their positions in Teladoc Health, with Golden State Wealth Management and National Bank of Canada increasing their holdings by 102.6% and 79.4% respectively.
• Teladoc Health reported a revenue of $631.90 million for the last quarter, which exceeded analyst expectations, though it had a negative net margin of 8.16%.

Hsbc Holdings PLC decreased its stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 53.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 184,252 shares of the health services provider's stock after selling 212,946 shares during the quarter. Hsbc Holdings PLC owned approximately 0.11% of Teladoc Health worth $1,481,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Cambridge Investment Research Advisors Inc. grew its position in shares of Teladoc Health by 60.8% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 39,738 shares of the health services provider's stock valued at $316,000 after purchasing an additional 15,030 shares during the period. Golden State Wealth Management LLC grew its position in shares of Teladoc Health by 102.6% in the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after purchasing an additional 1,690 shares during the period. Wedmont Private Capital grew its position in shares of Teladoc Health by 20.3% in the first quarter. Wedmont Private Capital now owns 16,086 shares of the health services provider's stock valued at $117,000 after purchasing an additional 2,715 shares during the period. Wealth Enhancement Advisory Services LLC boosted its position in Teladoc Health by 22.1% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider's stock worth $134,000 after acquiring an additional 2,662 shares during the last quarter. Finally, Vontobel Holding Ltd. boosted its position in Teladoc Health by 61.4% during the first quarter. Vontobel Holding Ltd. now owns 21,422 shares of the health services provider's stock worth $171,000 after acquiring an additional 8,152 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Truist Financial lowered their price target on shares of Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a research report on Tuesday, May 27th. Wells Fargo & Company lowered their price target on shares of Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating on the stock in a research report on Thursday, May 8th. Evercore ISI boosted their price target on shares of Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research report on Wednesday, July 9th. Mizuho assumed coverage on shares of Teladoc Health in a research report on Friday, July 25th. They set a "neutral" rating and a $10.00 price target on the stock. Finally, Bank of America lowered their price target on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 28th. Six investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat.com, Teladoc Health currently has an average rating of "Hold" and a consensus target price of $9.80.

Insider Activity

In other news, insider Adam C. Vandervoort sold 5,808 shares of the business's stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $39,842.88. Following the sale, the insider directly owned 69,773 shares of the company's stock, valued at approximately $478,642.78. The trade was a 7.68% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Fernando M. Rodrigues sold 4,174 shares of the business's stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $6.91, for a total transaction of $28,842.34. The disclosure for this sale can be found here. In the last three months, insiders have sold 18,656 shares of company stock valued at $128,189. Company insiders own 0.58% of the company's stock.

Teladoc Health Trading Down 1.9%

TDOC stock traded down $0.15 during trading on Friday, reaching $7.74. 3,533,595 shares of the stock were exchanged, compared to its average volume of 5,769,362. The company has a current ratio of 2.67, a quick ratio of 2.58 and a debt-to-equity ratio of 0.70. The business has a 50 day moving average price of $7.81 and a 200-day moving average price of $7.99. Teladoc Health, Inc. has a 1 year low of $6.35 and a 1 year high of $15.21. The firm has a market capitalization of $1.37 billion, a price-to-earnings ratio of -6.50 and a beta of 1.84.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, topping analysts' consensus estimates of ($0.27) by $0.08. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The company had revenue of $631.90 million for the quarter, compared to the consensus estimate of $621.91 million. During the same period in the previous year, the firm earned ($0.38) earnings per share. Teladoc Health's quarterly revenue was down 1.6% compared to the same quarter last year. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. On average, research analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.